Efficient CME

In August of 2024, an Alzheimer’s Association working group released revised clinical criteria for the diagnosis and staging of Alzheimer’s disease (AD), shifting it from a clinical to a biological definition. This reflects a dramatic shift in the role of biomarkers, particularly radiological, in the management of this disease since the introduction of anti-amyloid beta monoclonal antibodies (anti-Aβ mAbs). This activity walks learners through case scenarios designed to capture the integration of radiology from diagnosis of AD through initiation, monitoring, and identifying/managing AEs of anti-Aβ mAbs. Learn tips and tricks from practicing neurologists and radiologists to streamline care for your patients. Link: https://lnkd.in/dgQG_W_q #Alzheimers #CME #MedEd #radiology #neurology #amyloidtherapy #MER

Chronic inflammatory demyelinating polyneuropathy (CIDP) can manifest in vague and variable presentations that lead even experts astray in pursuit of its diagnosis. In this program, follow leading specialists – Drs Nicholas Silvestri, Christyn Edmunson, and Kelly Gwathmey – through real cases as they identify common pitfalls, tips and tricks, and novel therapeutic considerations to help optimize the diagnosis and management of this complex condition. Link: https://lnkd.in/eBtvxUxi #PACE #neurology #CME #neuropathy #meded

Have you ever wished you could actually “practice” medicine? If you’re looking to sharpen your skills in the diagnosis and treatment of migraine, this activity offers just that. With a crash course of expert tips followed by a clinical simulation, you can acquire knowledge and apply it directly to realistic patient scenarios. Take a journey through migraine: https://lnkd.in/eM8VtuqW #migraine #neurology #cme #Purdue

When you ask clinicians their preferred next step in a given clinical situation, there is always a caveat; what will insurance approve? In many cases, those two answers are not aligned. To help streamline the path to optimized care in narcolepsy and idiopathic hypersomnia, this program brought together both clinicians and payors to discuss tips for overcoming insurance-related barriers. Link: https://lnkd.in/eEkR9HqS #neurology #CME #Purdue #narcolepsy #idiopathichypersomnia?

In CME, we scour the globe for incredible clinicians every day to help on our quest to advance the medical field. But sometimes, we don’t have to look that far. It gives us great both sadness and excitement that, for the second time, one of our own is leaving the team to start medical school. Best of luck, Sabrina Vuong! You will be missed!

At EfficientCME, we are always looking for new and interesting ways to design education. But this is consistently one of our favorites. In this format, we ask practicing clinicians who treat but do not specialize in a disease to give us their most pressing questions about its management. Through this approach, we can get at the heart of what real clinicians need to know to improve their practices. For our latest program in this beloved format specific to multiple sclerosis, click here: https://lnkd.in/gi8Xvxs8 #multiplesclerosis #CME #neurology #Purdue

Wondering how to integrate the first disease modifying therapies for Alzheimer’s Disease (#AD), amyloid-targeting therapies (ATT), into your practice? In this interactive virtual grand rounds series, Efficient will bring an expert of your choosing directly to your clinic to provide insight into how they optimize this strategy for their patients. You will also be invited to submit your own questions/cases in advance to be directly integrated into the presentation, customizing the content to your practice’s specific needs. See the attached flyer for more information. To submit a request for your institution, email us at [email protected] #alzheimers #cme #neurology #MER #grandrounds

We now recognize that progressive pathologies can occur in any form of multiple sclerosis (#MS) at any point in the disease course. What are our best tools to identify and combat progression today? Are Bruton's tyrosine kinase inhibitors (#BTKi) the future? Join renowned MS experts – Drs. Jiwon Oh, Stephen Krieger, and Darin Okuda – on May 30th at 6:30 AM CT for our breakfast symposium in conjunction with the #CMSC2024 annual meeting as they explore the latest assessment tools, biomarkers, and disease-modifying therapies in our arsenal to address this complex phenomenon. Also, participate in their open dialogue on the potential of and recent updates with investigational BTKi’s and how they may shape the therapeutic landscape of MS. Register now: https://lnkd.in/e7bUE_wm #CME #neurology #DMT #MER?